1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
Article

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 1 2018, In : The Lancet. Oncology. 19, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin clinical cases: Use according to indication in diverse clinical scenarios

Grignani, G., Martín-Broto, J., Schuler, M. & Reichardt, P., Jun 1 2015, In : Future Oncology. 11, p. 15-24 10 p.

Research output: Contribution to journalArticle

Treatment of extraspinal painful bone metastases with percutaneous cementoplasty: A prospective study of 50 patients

Anselmetti, G. C., Manca, A., Ortega, C., Grignani, G., DeBernardi, F. & Regge, D., Nov 2008, In : CardioVascular and Interventional Radiology. 31, 6, p. 1165-1173 9 p.

Research output: Contribution to journalArticle

Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study

Gelderblom, H., Judson, I. R., Benson, C., Merimsky, O., Grignani, G., Katz, D., Freivogel, K. W., Stein, D., Jobanputra, M., Mungul, A., Manson, S. C. & Sanfilippo, R., Dec 2017, In : Acta Oncologica. 56, 12, p. 1769-1775 7 p.

Research output: Contribution to journalArticle

Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study*

Gelderblom, H., Judson, I. R., Benson, C., Merimsky, O., Grignani, G., Katz, D., Freivogel, K. W., Stein, D., Jobanputra, M., Mungul, A., Manson, S. C. & Sanfilippo, R., Dec 2 2017, In : Acta Oncologica. 56, 12, p. 1769-1775 7 p.

Research output: Contribution to journalArticle

Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy

Stacchiotti, S., Verderio, P., Messina, A., Morosi, C., Collini, P., Llombart-Bosch, A., Martin, J., Comandone, A., Cruz, J., Ferraro, A., Grignani, G., Pizzamiglio, S., Quagliuolo, V., Picci, P., Frustaci, S., Dei Tos, A. P., Casali, P. G. & Gronchi, A., Dec 1 2012, In : Cancer. 118, 23, p. 5857-5866 10 p.

Research output: Contribution to journalArticle